Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2026-05-26 @ 7:01 PM
Study NCT ID:
NCT00303966
Status:
TERMINATED
Last Update Posted:
2014-05-07
First Post:
2006-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2012-02688
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None